HALEON UK RESEARCH LIMITED
Get an alert when HALEON UK RESEARCH LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-09-25 (in 4mo)
Last made up 2025-09-11
Watchouts
Cash
£7M
+265.7% vs 2023
Net assets
£18M
-5.9% vs 2023
Employees
0
Average over period
Profit before tax
-£597K
-218% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
In October 2018, the Group announced its intention to close the manufacturing site in the Philippines by 2021 which was extended until April 2022. Decommissioning of the site was completed in July 2022. Consequently, these financial statements have been prepared on a basis other than that of a going concern (see note 2.1).
Name history
Renamed 2 times since incorporation
- HALEON UK RESEARCH LIMITED 2022-10-14 → present
- SMITHKLINE BEECHAM RESEARCH LIMITED 1990-12-10 → 2022-10-14
- BEECHAM RESEARCH LIMITED 1928-03-21 → 1990-12-10
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | -£204,000 | -£1,446,000 | |
| Profit before tax | £506,000 | -£597,000 | |
| Net profit | £585,000 | -£724,000 | |
| Cash | £1,980,000 | £7,241,000 | |
| Total assets less current liabilities | £18,873,000 | £18,953,000 | |
| Net assets | £18,763,000 | £17,654,000 | |
| Equity | £18,763,000 | £17,654,000 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | -1.1% | -7.6% | |
| Gearing (liabilities / total assets) | 1.7% | 9.4% | |
| Current ratio | 82.72x | 34.60x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“In October 2018, the Group announced its intention to close the manufacturing site in the Philippines by 2021 which was extended until April 2022. Decommissioning of the site was completed in July 2022. Consequently, these financial statements have been prepared on a basis other than that of a going concern (see note 2.1).”
Group structure
- HALEON UK RESEARCH LIMITED · parent
- Sterling Products International, Incorporated 100%
Significant events
- “After the balance sheet, the Company was subject to tax reviews and assessments. As a result, the Company recognised a provision of £1,173k in respect of the ongoing tax matters. The amount provided reflects management's best estimate of the expenditure required to settle the obligation at the reporting date, based on currently available information.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 32 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HALEON UK CORPORATE SECRETARY LIMITED | Corporate Secretary | 2022-04-06 | — | — |
| EL ANSARI, Khalid | Director | 2022-03-04 | Sep 1980 | British |
| HALEON UK CORPORATE DIRECTOR LIMITED | Corporate Director | 2022-04-06 | — | — |
| HALEON UK CORPORATE SECRETARY LIMITED | Corporate Director | 2022-04-06 | — | — |
Show 32 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BANKS, Valerie | Secretary | 1997-08-26 | 1998-05-18 |
| BRYANT, Karina Jane | Secretary | 1999-12-22 | 2002-01-18 |
| COOMBER, Caroline Daphne | Secretary | 1998-05-18 | 1999-12-22 |
| HORLER, Alison Marie | Secretary | — | 1993-10-05 |
| MCCLINTOCK, Clare Alexandra | Secretary | 1993-10-05 | 1997-08-26 |
| WILBRAHAM, Simon Nicholas | Secretary | 1998-08-13 | 2001-02-22 |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Secretary | 2002-01-18 | 2022-04-06 |
| ARISTIDOU, Antrinkos Andrew | Director | 2019-08-19 | 2020-07-31 |
| BARRETT, Paul Michael | Director | — | 2001-03-14 |
| BERRY, Antony Rodney | Director | 1994-07-29 | 1998-08-13 |
| BLACKBURN, Paul Frederick | Director | 2009-09-09 | 2016-03-01 |
| BONDY, Rupert | Director | 2000-01-28 | 2001-03-14 |
| BOX, Jonathan Wilson | Director | 2016-06-17 | 2017-11-30 |
| CARPANINI, Damien Raphael | Director | 1994-09-12 | 1999-12-23 |
| COOPER, Nicholas Ian | Director | 2019-09-11 | 2020-03-10 |
| CURL, Andrew Robert | Director | — | 2001-03-14 |
| DOLBEAR, Belinda Jane | Director | 1994-09-12 | 1998-09-04 |
| EAGLEN, Robin John, Doctor | Director | 1994-07-29 | 1996-12-18 |
| FOSTER-HAWES, Melanie | Director | 2016-06-17 | 2019-01-15 |
| GARG, Parul | Director | 2022-03-04 | 2023-04-30 |
| GREEN, Richard | Director | 2019-01-15 | 2021-10-15 |
| HURST, Simon Jeremy | Director | — | 1994-09-12 |
| LUCKHAM, Anthony Arthur | Director | — | 1996-09-27 |
| MCCLINTOCK, Clare Alexandra | Director | 2000-01-28 | 2001-02-22 |
| PROKOPCHUK, Eugene | Director | 2020-07-31 | 2022-03-04 |
| ROBERTS, Sean James Lomax | Director | 1998-09-04 | 2001-03-14 |
| ROBINSON, Cynthia Ann | Director | — | 1994-09-12 |
| TATTERSHALL, Richard Philip | Director | 2017-11-30 | 2020-03-10 |
| WALKER, Adam | Director | 2015-09-14 | 2016-08-01 |
| WHITTAKER, Rodney Martin | Director | — | 1999-12-23 |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Director | 2001-03-13 | 2022-04-06 |
| GLAXO GROUP LIMITED | Corporate Director | 2001-03-13 | 2022-04-06 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Haleon Uk Holdings (No.7) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-09-01 | Active |
| Prism Pch Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-12-13 | Ceased 2021-09-01 |
| Consumer Healthcare Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-07-02 | Ceased 2019-12-13 |
| Glaxosmithkline Consumer Healthcare Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2019-07-02 |
Filing timeline
Last 20 of 227 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-06-16 RESOLUTIONS Resolution
- 2025-06-16 MA Memorandum articles
- 2025-06-12 CC04 Statement of companys objects
- 2022-10-14 CERTNM Certificate change of name company PDF
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-01-03 | AA | accounts | Accounts with accounts type full | |
| 2025-09-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-16 | RESOLUTIONS | resolution | Resolution | |
| 2025-06-16 | MA | incorporation | Memorandum articles | |
| 2025-06-12 | CC04 | change-of-constitution | Statement of companys objects | |
| 2025-03-14 | AA | accounts | Accounts with accounts type full | |
| 2024-09-12 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-09-11 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-12-19 | AA | accounts | Accounts with accounts type full | |
| 2023-10-20 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-10-17 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-09-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-05 | CH02 | officers | Change corporate director company with change date | |
| 2023-06-05 | CH04 | officers | Change corporate secretary company with change date | |
| 2023-06-05 | CH02 | officers | Change corporate director company with change date | |
| 2023-05-19 | CH04 | officers | Change corporate secretary company with change date | |
| 2023-05-19 | CH02 | officers | Change corporate director company with change date | |
| 2023-05-19 | CH02 | officers | Change corporate director company with change date | |
| 2023-05-03 | TM01 | officers | Termination director company with name termination date | |
| 2022-10-14 | CERTNM | change-of-name | Certificate change of name company |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
+265.7%
£1,980,000 £7,241,000
-
Net assets
-5.9%
£18,763,000 £17,654,000
-
Employees
—
Not reported
-
Operating profit
-608.8%
-£204,000 -£1,446,000
-
Profit before tax
-218%
£506,000 -£597,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers